Revenue
0 USD
2008-06-30 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
Medical Care Technologies Inc.
EDGAR31 filing records in this dataset, filed from 2008-08-14 to 2012-11-19. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 742 USD Source
Exact value
742 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 3.24 billion shares Source
Exact value
3243896955 shares
Reported share-count change
1,226.91% · 3 billion shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
-2.88 million USD
2011-10-01 – 2012-09-30
Exact inputs and evidence
Operating cash flow
-300 thousand USD
2011-10-01 – 2012-09-30
Exact inputs and evidence
- Operating cash flow: -371920 USD · 2011-01-01 – 2011-12-31 Source
- Operating cash flow: -269807 USD · 2011-01-01 – 2011-09-30 Source
- Operating cash flow: -58139 USD · 2012-01-01 – 2012-03-31 Source
- Operating cash flow: -109959 USD · 2012-01-01 – 2012-06-30 Source
- Operating cash flow: -58139 USD · 2012-01-01 – 2012-03-31 Source
- Operating cash flow: -197655 USD · 2012-01-01 – 2012-09-30 Source
- Operating cash flow: -109959 USD · 2012-01-01 – 2012-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2012-11-19.
Financial data available through: 2011-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 4 of 11 periods available· newest 2011-12-31
- Operating cash flow: 4 of 11 periods available· newest 2011-12-31
- Capital expenditure: 2 of 11 periods available· newest 2011-12-31
- Total assets: 4 of 11 periods available· newest 2011-12-31
- Total liabilities: 4 of 11 periods available· newest 2011-12-31
- Current assets: 4 of 11 periods available· newest 2011-12-31
- Current liabilities: 4 of 11 periods available· newest 2011-12-31
- Cash and cash equivalents: 4 of 11 periods available· newest 2011-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2011-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 265,384Prior period
−USD 2.19 million
–
Current period
−USD 1.92 million
–
Exact inputs and evidence
-1923887 − -2189271 = 265384 USD
-2189271 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source-1923887 USD · 2011-01-01 – 2011-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 181,985Prior period
−USD 189,935
–
Current period
−USD 371,920
–
Exact inputs and evidence
-371920 − -189935 = -181985 USD
-189935 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source-371920 USD · 2011-01-01 – 2011-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+USD 6,200Prior period
USD 0
–
Current period
USD 6,200
–
Exact inputs and evidence
6200 − 0 = 6200 USD
0 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source6200 USD · 2011-01-01 – 2011-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2008 2008-01-01 – 2008-12-31 | −USD 55,742 Exact valueExact value: -55742 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21,050 Exact valueExact value: -21050 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2009 2009-01-01 – 2009-12-31 | −USD 85,121 Exact valueExact value: -85121 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82,050 Exact valueExact value: -82050 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2010 2010-01-01 – 2010-12-31 | −USD 2.19 million Exact valueExact value: -2189271 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 189,935 Exact valueExact value: -189935 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 189,935 Calculation and evidence-189935 − 0 USD Exact free cash flow: -189935 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2011 2011-01-01 – 2011-12-31 | −USD 1.92 million Exact valueExact value: -1923887 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 371,920 Exact valueExact value: -371920 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6,200 Exact valueExact value: 6200 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 378,120 Calculation and evidence-371920 − 6200 USD Exact free cash flow: -378120 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
31 filings · 483 latest values · 483 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001404593, 1404593, MDCE, edgar:1404593
Also known as AM OIL RESOURCES & TECHNOLOGY INC., Aventerra Explorations, Inc., MEDICAL CARE TECHNOLOGIES INC., Medical Care Technologies Inc.